TRT and testosterone optimisation: separating UK clinic reality from alpha-male TikTok

What's this video probably claiming?

Accounts like @alphamale.tips typically push a consistent narrative: that most men are walking around with suboptimal testosterone, that mainstream medicine is either ignorant of or deliberately ignoring this problem, and that TRT is the missing piece for energy, muscle, libido, and mental clarity. Given the hashtags, particularly #testosterone, #gains, and #trt, this video likely frames testosterone replacement as something men should be actively seeking out, possibly suggesting that 'normal' lab ranges are set too low, that GPs in the UK are reluctant to help, or that symptoms alone justify treatment. There may also be references to specific protocols, cycle structures, or supplement stacks that supposedly 'optimise' hormone levels without a prescription. That last category is where things get genuinely risky, and where the gap between influencer advice and regulated clinical practice becomes a real patient safety issue.

What does the science actually show?

The clinical picture on testosterone replacement is more nuanced than TikTok allows. Diagnosed hypogonadism, defined as consistently low serum testosterone combined with specific symptoms, does respond well to TRT. The TRAVERSE trial (Lincoff et al., 2023, NEJM), the largest cardiovascular safety study to date with over 5,200 men, found no significant increase in major cardiovascular events in men on testosterone therapy versus placebo, which partially addressed a long-standing safety concern. However, the trial enrolled men aged 45-80 with pre-existing or high cardiovascular risk, so extrapolating to healthy men in their 20s and 30s is a stretch. A 2020 meta-analysis in The Lancet Diabetes and Endocrinology (Yeap et al.) confirmed that TRT improves sexual function and bone density in hypogonadal men, but improvements in mood and cognition were modest and inconsistent. Testosterone also suppresses the hypothalamic-pituitary-gonadal axis, meaning exogenous testosterone typically shuts down endogenous production. Fertility impact is real and often irreversible without adjunct therapies like hCG.

Where does the social media noise diverge from clinical reality?

The biggest divergence is in patient selection. UK NHS criteria for TRT require two morning fasting testosterone measurements below 12 nmol/L (roughly 346 ng/dL), taken at least four weeks apart, alongside clinical symptoms. Many private clinics and almost all influencer-adjacent content treat anything below 15-20 nmol/L as a crisis requiring intervention. That is not evidence-based, it is market creation. There is also persistent misrepresentation of 'testosterone optimisation' as a separate, safer category from TRT, when the pharmacology is identical. Content in this space routinely fails to mention that TRT-adjacent supplement stacks, particularly those involving ashwagandha, zinc mega-dosing, or unlicensed DHEA products, have very limited evidence for men with clinically normal testosterone. A 2021 review in World Journal of Men's Health found ashwagandha modestly increased testosterone in infertile or stressed men, not in healthy men with normal baseline levels. The #gains framing also implies performance benefit, which is a different regulatory and ethical territory entirely.

What should you actually know?

If you are experiencing symptoms that could be consistent with low testosterone, including persistent fatigue, reduced libido, erectile dysfunction, or mood changes, the right first step is a GP appointment, not a TikTok video. In the UK, the British Society for Sexual Medicine guidelines provide clear criteria for diagnosis and treatment. Symptoms alone are not sufficient for a diagnosis. Private TRT clinics vary considerably in their clinical standards, and men should ask specifically about monitoring protocols, including haematocrit, PSA, and lipid panels. Polycythaemia (elevated red blood cell count) is a real, dose-dependent side effect of testosterone therapy that increases stroke and clotting risk. Any content that discusses TRT without mentioning fertility suppression, cardiovascular monitoring, or the need for regular blood work is leaving out information that directly affects your safety. Treat it accordingly.